跳至主要内容
临床试验/NCT06312657
NCT06312657终止早期 1 期

Behavioral Effects of Drugs Inpatient 44: Neurobehavioral Mechanisms of Opioid Choice

Joshua A. Lile, Ph.D.1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2023年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
终止
发起方
入组人数
2
试验地点
1
主要终点
Task choices

研究概览

简要总结

The objective of this protocol is to use probabilistic choice tasks, reinforcement learning modeling and fMRI to determine the neurobehavioral mechanisms of decision-making in individuals with opioid use disorder and physical opioid dependence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Basic Science
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals must meet criteria for moderate/severe opioid use disorder, report past month opioid misuse, and be physically dependent on short-acting opioids (e.g., heroin, hydromorphone, fentanyl), as evidenced by either urine sample positive for recent opioid use during each visit or if opioid negative, displaying frank withdrawal during screening.
  • History of intravenous opioid use.
  • Baseline O2 saturation of 95% or greater.
  • Between the ages of 18-50 years.
  • Female subjects must be using an effective form of birth control (e.g., birth control pills, surgical sterilization, IUD, cervical cap with a spermicide, or abstinence). Urine pregnancy tests will be conducted prior to sessions to ensure that female subjects do not participate if pregnant.
  • Able to speak and read English.
  • Otherwise healthy.

排除标准

  • History of, or current, clinically significant physical disease (e.g., respiratory disease [asthma, COPD, sleep apnea], impaired cardiovascular functioning, seizure disorder or CNS tumors) or current or past history of psychiatric disorder that would limit compliance in the studies, other than substance use disorder.
  • Meet diagnostic criteria for psychoactive substance use disorder for substances other than opioids (OUD subjects only) or nicotine/caffeine that would require detoxification (i.e., alcohol, benzodiazepines or barbiturates). Negative urine/breath samples for these substances, and the absence of withdrawal, will be required during screening.
  • Contraindications for MRI scanning (e.g., pacemaker, metal implants, claustrophobia, or any other implanted medical device).
  • Vision or hearing problems that would preclude completion of experimental tasks.
  • Poor venous access.
  • Regular use of other medications, with the exception of hormone-based contraceptives for female subjects, daily multivitamins or short-term antibiotic prescriptions.
  • At risk for respiratory complications and have predictors of difficult bag mask ventilation (e.g., dentures, very full beard), in case emergency respiratory intervention is needed.
  • Seeking treatment for SUD or currently taking buprenorphine or methadone as the primary opioid of use.

研究组 & 干预措施

Money-vs-money task

Experimental

干预措施: Drug Cue (Behavioral)

Drug-vs-money task

Experimental

干预措施: Money (Behavioral)

Drug-vs-money task

Experimental

干预措施: Withdrawal (Drug)

结局指标

主要结局

Task choices

时间窗: Tasks will take approximately 45-60 minutes to complete. Participants will complete 5 sessions in which a choice task will be administered.

Number of choices of each option selected.

次要结局

未报告次要终点

研究者

发起方
Joshua A. Lile, Ph.D.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Joshua A. Lile, Ph.D.

Professor

University of Kentucky

研究点 (1)

Loading locations...

相似试验